Previous studies have revealed that the quantity and function of CD8+ T cells decline with increasing risk stratification of MDS, reflecting CD8+ T cell suppression in the background of disease progression and clonal expansion in MDS; and CD8+ T cell suppression will further exacerbate the progression of MDS [46,51,52]. This evidence concerns the gene CD8A and myelodysplastic syndrome.